These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35171522)

  • 1. Joint status of patients with nonsevere hemophilia A.
    Zwagemaker AF; Kloosterman FR; Hemke R; Gouw SC; Coppens M; Romano LGR; Kruip MJHA; Cnossen MH; Leebeek FWG; Hutten BA; Maas M; Fijnvandraat K
    J Thromb Haemost; 2022 May; 20(5):1126-1137. PubMed ID: 35171522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor correlation between biomarkers and MRI-detected joint damage in a cross-sectional study of persons with nonsevere hemophilia A (DYNAMO study).
    Kloosterman FR; Zwagemaker AF; Bay-Jensen AC; Cnossen MH; Kruip MJHA; Leebeek FWG; Hemke R; Maas M; Fijnvandraat K; Gouw SC; Coppens M
    J Thromb Haemost; 2023 Jul; 21(7):1813-1823. PubMed ID: 37019364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bleeding phenotype in people with nonsevere hemophilia.
    Kloosterman FR; Zwagemaker AF; Bagot CN; Beckers EAM; Castaman G; Cnossen MH; Collins PW; Hay C; Hof M; Laros-van Gorkom B; Leebeek FWG; Male C; Meijer K; Pabinger I; Shapiro S; Coppens M; Fijnvandraat K; Gouw SC
    Blood Adv; 2022 Jul; 6(14):4256-4265. PubMed ID: 35533261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging evidence for subclinical joint bleeding in a Dutch population of people with severe hemophilia on prophylaxis.
    van Leeuwen FHP; van Bergen EDP; Timmer MA; van Vulpen LFD; Schutgens REG; de Jong PA; Fischer K; Foppen W
    J Thromb Haemost; 2023 May; 21(5):1156-1163. PubMed ID: 36758725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic Resonance Imaging of Hemophilic Joints: Correlations with the Bleeding Phenotype and Physical Examination.
    Spasov N; Dimitrova-Popova D; Traikova-Djambazova N; Spasova M; Bosheva M
    Folia Med (Plovdiv); 2020 Dec; 62(4):762-768. PubMed ID: 33415922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of late prophylaxis in hemophilia on joint status: a randomized trial.
    Manco-Johnson MJ; Lundin B; Funk S; Peterfy C; Raunig D; Werk M; Kempton CL; Reding MT; Goranov S; Gercheva L; Rusen L; Uscatescu V; Pierdominici M; Engelen S; Pocoski J; Walker D; Hong W
    J Thromb Haemost; 2017 Nov; 15(11):2115-2124. PubMed ID: 28836341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled, cross-sectional MRI evaluation of joint status in severe haemophilia A patients treated with prophylaxis vs. on demand.
    Oldenburg J; Zimmermann R; Katsarou O; Theodossiades G; Zanon E; Niemann B; Kellermann E; Lundin B;
    Haemophilia; 2015 Mar; 21(2):171-179. PubMed ID: 25470205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The factor VIII treatment history of non-severe hemophilia A.
    Abdi A; Kloosterman FR; Eckhardt CL; Male C; Castaman G; Fischer K; Beckers EAM; Kruip MJHA; Peerlinck K; Mancuso ME; Santoro C; Hay CR; Platokouki H; van der Bom JG; Gouw SC; Fijnvandraat K; Hart DP;
    J Thromb Haemost; 2020 Dec; 18(12):3203-3210. PubMed ID: 32877570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleeding phenotype according to factor level in 825 children with nonsevere hemophilia: data from the PedNet cohort.
    de Kovel MS; Escuriola-Ettingshausen C; Königs C; Ranta S; Fischer K;
    J Thromb Haemost; 2024 Sep; 22(9):2460-2469. PubMed ID: 38866249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Efficacy of Recombinant FVIII Low-Dose Prophylaxis in Chinese Pediatric Patients With Severe Hemophilia A: A Retrospective Analysis From the ReCARE Study.
    Yao W; Xiao J; Cheng X; Feng G; Li C; Zhang X; Hu Q; Xu W; Sun J; Yang R; Li X; Zhou R; Lian S; Gu J; Wu J; Zhao Y; Wu R
    Clin Appl Thromb Hemost; 2017 Oct; 23(7):851-858. PubMed ID: 27920236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Joint status and related risk factors in patients with severe hemophilia A: a single-center cross-sectional study.
    Zhao L; Yang H; Li Y; Wang Z; Zhou L; Zhao X; Peng J
    Hematology; 2022 Dec; 27(1):80-87. PubMed ID: 34964431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI predicts 5-year joint bleeding and development of arthropathy on radiographs in hemophilia.
    Foppen W; van der Schaaf IC; Beek FJA; Mali WPTM; Fischer K
    Blood Adv; 2020 Jan; 4(1):113-121. PubMed ID: 31917842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of short-term full-dose prophylaxis in adult Chinese patients with severe hemophilia A].
    Sun X; Zhuang J; Zhou X; Li H; Liu Z; Sun J
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1222-1227. PubMed ID: 30377129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging and joint outcomes in boys with severe hemophilia A treated with tailored primary prophylaxis in Canada.
    Kraft J; Blanchette V; Babyn P; Feldman B; Cloutier S; Israels S; Pai M; Rivard GE; Gomer S; McLimont M; Moineddin R; Doria AS
    J Thromb Haemost; 2012 Dec; 10(12):2494-502. PubMed ID: 23067060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy of haemophilia early arthropathy detection with ultrasound (HEAD-US): a comparative magnetic resonance imaging (MRI) study.
    Plut D; Kotnik BF; Zupan IP; Kljucevsek D; Vidmar G; Snoj Z; Martinoli C; Salapura V
    Radiol Oncol; 2019 Jun; 53(2):178-186. PubMed ID: 31194690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. The Orthopaedic Outcome Study Group.
    Aledort LM; Haschmeyer RH; Pettersson H
    J Intern Med; 1994 Oct; 236(4):391-9. PubMed ID: 7931042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimum factor VIII levels to prevent joint bleeding in mild hemophilia A.
    Agosti P; Siboni SM; Scardo S; Torri A; Gualtierotti R; Peyvandi F
    Blood Adv; 2023 Dec; 7(23):7209-7215. PubMed ID: 37871302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of FVIII doses on joint structure and function in adolescents with severe hemophilia A: mid-term results of a prospective cohort study].
    Meng L; Zhuang J; Sun X; Liu Z; Zhou X; Liu H; Zhou F; Li Y; Sun J
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Apr; 41(4):536-542. PubMed ID: 33963712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SPINART study: validation of the extended magnetic resonance imaging scale for evaluation of joint status in adult patients with severe haemophilia A using baseline data.
    Hong W; Raunig D; Lundin B
    Haemophilia; 2016 Nov; 22(6):e519-e526. PubMed ID: 27642172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome in moderate haemophilia.
    den Uijl I; Biesma D; Grobbee D; Fischer K
    Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s330-6. PubMed ID: 23245711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.